Ironwood Pharmaceuticals Inc (IRWD) — Cash Flow Reinvestment Rate
Ironwood Pharmaceuticals Inc (IRWD) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $5.12 Million. Check IRWD cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ironwood Pharmaceuticals Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Ironwood Pharmaceuticals Inc across 7 annual periods. Explore IRWD long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Ironwood Pharmaceuticals Inc (2019–2025)
Year-by-year capital reinvestment analysis for Ironwood Pharmaceuticals Inc. For live market cap and broader valuation context, see IRWD stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $34.00K | $127.04 Million | $34.00K | ▼ -90.2% |
| 2024 | 0.00x | $284.00K | $103.55 Million | $142.00K | ▼ -100.0% |
| 2023 | 5.57x | $1.02 Billion | $183.43 Million | $273.00K | ▲ +560887.6% |
| 2022 | 0.00x | $272.00K | $273.76 Million | $136.00K | ▼ -50.9% |
| 2021 | 0.00x | $530.00K | $261.89 Million | $265.00K | ▼ -90.7% |
| 2020 | 0.02x | $3.68 Million | $168.84 Million | $1.84 Million | ▼ -98.7% |
| 2019 | 1.71x | $18.33 Million | $10.72 Million | $7.19 Million | — |